Rocket Pharmaceuticals (RCKT) Other Gross PP&E Adjustments: 2016-2025
Historic Other Gross PP&E Adjustments for Rocket Pharmaceuticals (RCKT) over the last 10 years, with Sep 2025 value amounting to $14.6 million.
- Rocket Pharmaceuticals' Other Gross PP&E Adjustments rose 41.71% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.1 million, marking a year-over-year increase of 1495.74%. This contributed to the annual value of $8.4 million for FY2024, which is 142.25% up from last year.
- As of Q3 2025, Rocket Pharmaceuticals' Other Gross PP&E Adjustments stood at $14.6 million, which was up 129.63% from $6.4 million recorded in Q2 2025.
- Rocket Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at $37.8 million during Q1 2023, with a 5-year trough of -$32.5 million in Q4 2021.
- Its 3-year average for Other Gross PP&E Adjustments is $6.7 million, with a median of $7.7 million in 2024.
- Over the last 5 years, Rocket Pharmaceuticals' Other Gross PP&E Adjustments had its largest YoY gain of 13,150.00% in 2024, and its largest YoY loss of 89.15% in 2024.
- Rocket Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at -$32.5 million in 2021, then increased by 12.82% to -$28.3 million in 2022, then surged by 30.10% to -$19.8 million in 2023, then soared by 142.25% to $8.4 million in 2024, then skyrocketed by 41.71% to $14.6 million in 2025.
- Its Other Gross PP&E Adjustments stands at $14.6 million for Q3 2025, versus $6.4 million for Q2 2025 and $7.7 million for Q1 2025.